Catalyst Funds Management Pty LTD Organogenesis Holdings Inc. Transaction History
Catalyst Funds Management Pty LTD
- $662 Billion
- Q3 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 12,900 shares of ORGO stock, worth $58,437. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,900Holding current value
$58,437% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding ORGO
# of Institutions
126Shares Held
69.1MCall Options Held
39.7KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.1MShares$55 Million3.34% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$22.8 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...